EGFR and central nervous system cancer: This modulatory effect of NOTCH3 can be predominantly attributed to NOTCH target genes as well as its potential cooperation with major aberrant signaling pathways in malignant glioma such as EGFR, C-MYC and CCND1, which are all often altered in glioma.